Recursion Pharmaceuticals, Inc. RXRX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s operating lease liabilities (current)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported operating lease liabilities (current) of $13.09M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s operating lease liabilities (current) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s operating lease liabilities (current) increased by 10.4% year-over-year, from $11.85M to $13.09M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.